FDA Issues New Action Plan on Artificial Intelligence/Machine Learning-Based Software as a Medical Device
February 18, 2021
The Food and Drug Administration recently published a new Action Plan for how the agency will evaluate artificial intelligence and machine learning-based software when used as a medical device. On this episode of CalCurrent, digital health technology partner Eric Kintner discusses the FDA’s new Action Plan and how it may serve as a roadmap for future regulations.
The purpose of this podcast is to provide information on current topics of general interest and nothing herein shall be construed to create, offer, or memorialize the existence of an attorney-client relationship. The content should not be considered legal advice or opinion, because it may not apply to the specific facts of a particular matter. As guidance in areas is constantly changing and evolving, you should consider checking for updated guidance, or consult with legal counsel, before making any decisions. The opinions expressed during this podcast are the opinions of the individual only and do not reflect the opinions or position of Snell & Wilmer or any of its individual attorneys.